Delivery Order SPE2DB22D2206-SPE2DB25FJM33
- Not listed
- The Defense Logistics Agency awarded a $34,669.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits, with an ultimate completion date of July 24, 2025. This competitively awarded contract, issued on July 23, 2025, carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,266.27 by the Defense Logistics Agency on August 12, 2025, for the supply of Betaseron 0.3 mg kits. This firm fixed-price delivery order, which carries an ultimate completion date of August 13, 2025, represents a competitively awarded contract with no set-aside designation. The award is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $16,283.25 to AmerisourceBergen Drug Corp for the supply of Betaseron 0.3 mg kits, with an ultimate completion date of August 4, 2025. This firm fixed price delivery order, awarded on August 1, 2025, represents a non-competitive award and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation, reflecting the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,153.78 to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and is being performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is fulfilling this order...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $38,432.45 delivery order contract is for the supply of BETASERON 0.3 MG KITS, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of January 8, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,155.37, is for the supply of BETASERON 0.3 MG KITS, a specialty medication. The contract has an ultimate completion date of March 11, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- The Defense Logistics Agency has awarded Amerisourcebergen Drug Corp, through its Corporate Office division, a firm fixed price delivery order contract valued at $9,790.63 to provide BETASERON 0.3 MG KITS. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $14,944.37 firm fixed-price delivery order contract is for the supply of the drug BETASERON 0.3 MG KITS and has a performance period through June 21, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BETASERON 0.3 MG KITS, a pharmaceutical product, with a firm fixed price ceiling value of $21,397.77. The delivery order has an ultimate completion date of May 14, 2025. This contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,673.70 firm-fixed-price delivery order covers the supply of BETASERON 0.3 MG KITS, a specialty medication, with a period of performance through January 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJM33Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $28,856.00 to AmerisourceBergen Drug Corp for the supply of Betaseron 0.3 mg kits. The contract is firm fixed price with no set-aside designation and was competitively awarded. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The work will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025, one day after the award date of August 18, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's DLA IDC serves as a comprehensive global pharmaceutical support vehicle enabling supply of a broad range of pharmaceuticals and medical supplies to military healthcare programs worldwide. The Betaseron kits being delivered under this order support the Defense Health Agency and other government healthcare systems requiring immunological and neurological therapeutics as part of the broader military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.9k | 8/18/25 |